OnCare Hawaii Inc., the largest cancer care provider in the state, has selected IntelliDose to manage complex chemotherapy treatments at its four sites.

"After extensive reviews, OnCare Hawaii chose IntelliDose for its ability to manage the unique demands of the oncology specialty," the company said in a news release.

IntelliDose transforms the manual process of chemotherapy regimen calculations into electronically verified orders. It will allow OnCare Hawaii to standardize all of its chemotherapy orders and administrations, ensuring the highest levels of patient safety and efficiency practice-wide. It also eliminates the high costs and potential for error associated with hand-written orders, the company said.

OnCare Hawaii joins more than 500 oncologists at leading hospitals, health networks and private practices that rely on IntelliDose to manage and track increasingly complex chemotherapy regimens for more than 19,500 patients each month.